{"product_id":"2023-psychopharmacology-in-cancer-care","title":"2023 Psychopharmacology in Cancer Care: An Update for Clinicians of All Disciplines","description":"\u003ch2\u003e\u003cspan style=\"font-size: 22px;\"\u003eSpecialties\u003c\/span\u003e\u003c\/h2\u003e\n\u003cdiv class=\"prod-format\"\u003e\n\u003cdiv class=\"prod-title\"\u003e\n\u003cdiv class=\"activitysectionbold\"\u003e\n\u003cdiv\u003e\n\u003cem\u003eSpecialties\u003c\/em\u003e – Behavioral Care, Critical Care, General and Family Practice, Geriatric Medicine, Hematology, Integrative Medicine, Internal Medicine, Medical Oncology, Neurology, Nurse Anesthetist, Nurse Practitioner, Nursing, Pain Medicine, Psychiatry, Psychology, Social Work\u003c\/div\u003e\n\u003c\/div\u003e\n\u003cdiv\u003e\n\u003cbr\u003e\u003cbr\u003e2023 Psychopharmacology in Cancer Care: An Update for Clinicians of All Disciplines Clinicians have numerous tools at their disposal to help adult cancer patients dealing with symptoms of depression, anxiety, and other cancer sequelae. \u003cstrong\u003ePsychiatric medications are most frequently prescribed to cancer patients by oncologists and general practitioners, however, psychiatric syndromes are often underdiagnosed and undertreated.\u003c\/strong\u003e\n\u003cbr\u003e\u003cstrong\u003e \u003c\/strong\u003eFew oncology practices have dedicated psychiatric consultants familiar with the nuances of Psycho-Oncology. Even when patients receive psychotropic medications appropriately, they may have problems that arise before their next oncology visit or before they see the person who prescribed their psychiatric medications. Psychologists, nurses, and social workers play an essential role in identifying psychological and physical symptoms as well as both beneficial and problematic medication effects as they provide frontline psychosocial interventions and support for cancer patients.\u003cbr\u003e\u003cbr\u003eThis course is \u003cstrong\u003edesigned for the non-prescribing psycho-oncology clinician as well as the psychiatrist who is new to the world of Psycho-pharmaco-oncology\u003c\/strong\u003e. Oncologists, palliative care clinicians, advanced practice nurses, and oncology nurses will find this course useful as well. The course will \u003cstrong\u003efocus on key target disorders and symptoms amenable to psychopharmacological intervention\u003c\/strong\u003e, including anxiety, depression, delirium, sleep disturbance, pain, fatigue, and weight and appetite loss.\u003cbr\u003e\u003cbr\u003eThe course will also include \u003cstrong\u003eupdates on COVID-19-related delirium and the use of novel interventions\u003c\/strong\u003e including ketamine, medical marijuana, and psilocybin for depression, anxiety, and pain. Participants will learn to identify psychological reactions to medical conditions or treatments; psychiatric presentations of medical conditions or treatments; medical presentations of psychiatric conditions and common medical complications of psychiatric conditions or treatments.\u003cbr\u003e\u003cbr\u003e\n\u003c\/div\u003e\n\u003cstrong\u003e2023 Program Highlights\u003c\/strong\u003e\u003cbr\u003e\u003cbr\u003eThis year’s program includes topics on:\u003cbr\u003e\u003cul\u003e\n\u003cli\u003e\n\u003cstrong\u003eDepressive Disorders \u003c\/strong\u003e(Andrew Roth, MD)\u003c\/li\u003e\n\u003cli\u003e\n\u003cstrong\u003eDelirium\u003c\/strong\u003e (William Breitbart, MD)\u003c\/li\u003e\n\u003cli\u003e\n\u003cstrong\u003eAnxiety Disorders \u003c\/strong\u003e(Andrew Roth, MD)\u003c\/li\u003e\n\u003cli\u003e\n\u003cstrong\u003eSleep Disorders\u003c\/strong\u003e (Yesne Alici, MD)\u003c\/li\u003e\n\u003cli\u003e\n\u003cstrong\u003eCancer-Related Fatigue\u003c\/strong\u003e (William Breitbart, MD)\u003c\/li\u003e\n\u003cli\u003e\n\u003cstrong\u003ePain\u003c\/strong\u003e (Natalie Moryl, MD)\u003c\/li\u003e\n\u003cli\u003e\n\u003cstrong\u003eWeight and Appetite Loss \u003c\/strong\u003e(Yesne Alici, MD)\u003c\/li\u003e\n\u003cli\u003e\n\u003cstrong\u003eCancer and Cancer-Treatment Related Cognitive Changes \u003c\/strong\u003e(Yesne Alici, MD)\u003c\/li\u003e\n\u003cli\u003e\n\u003cstrong\u003eNovel Psychopharmacologic Interventions in Oncology\u003c\/strong\u003e (Christian Bjerre Real, MD, MMCI, FAPA)\u003c\/li\u003e\n\u003c\/ul\u003e\n\u003cbr\u003eAdditionally, there will be ample time during program breaks to meet the faculty and ask questions. \u003ca href=\"https:\/\/mskcc.cloud-cme.com\/Assets\/mskcc\/data\/Psychopharm_2023_Brochure.pdf\" rel=\"noopener\" target=\"_blank\"\u003eView the course brochure.\u003c\/a\u003e\n\u003cbr\u003e\u003ch4 class=\"activitysectionbold\"\u003eObjectives\u003c\/h4\u003e\n\u003col\u003e\n\u003cli\u003eDescribe basic psycho-pharmaco-oncology principles for understanding and treating anxiety, depression and delirium in people with cancer.\u003c\/li\u003e\n\u003cli\u003eDiscuss basic psycho-pharmaco-oncology principles for understanding and improving quality of life and psychiatric palliative care in people with cancer, including managing cognitive changes, insomnia, fatigue, poor appetite and weight loss, and pain.\u003c\/li\u003e\n\u003cli\u003eIdentify the nuances of psycho-pharmaco-oncology related to COVID-19 related delirium and the use of novel interventions including ketamine, medical marijuana, and psilocybin for depression, anxiety, and pain in people with cancer.\u003c\/li\u003e\n\u003c\/ol\u003e\n\u003cbr\u003e \u003cbr\u003e\u003cbr\u003e\n\u003c\/div\u003e\n\u003c\/div\u003e","brand":"meducours","offers":[{"title":"Default Title","offer_id":42954285056098,"sku":"MED-AMB00239","price":25.0,"currency_code":"USD","in_stock":true}],"thumbnail_url":"\/\/cdn.shopify.com\/s\/files\/1\/0662\/9549\/6802\/files\/40PhotoFixerBot_18-08-46_UTC.jpg?v=1779369965","url":"https:\/\/meducourse.com\/products\/2023-psychopharmacology-in-cancer-care","provider":"Meducourse","version":"1.0","type":"link"}